Overview
Marie-bernadette Aretin practices practicing medicine in Vienna, Austria.
Their clinical expertise encompasses Chronic T-Cell Leukemia (CTCL), Prolymphocytic Leukemia, and Head and Neck Squamous Cell Carcinoma (HNSCC).
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marie-bernadette Aretin
Is Marie-bernadette Aretin a top-rated expert for Chronic T-Cell Leukemia (CTCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Marie-bernadette Aretin is classified as an Experienced expert for Chronic T-Cell Leukemia (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marie-bernadette Aretin participate in research or clinical trials?
Yes. Marie-bernadette Aretin has published 14 articles and abstracts on conditions like Chronic T-Cell Leukemia (CTCL). You can view a list of Marie-bernadette Aretin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic T-Cell Leukemia (CTCL)Aretin isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Prolymphocytic LeukemiaAretin isExperienced. Learn about Prolymphocytic Leukemia.